伤口敷料市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、最终用途、地区和竞争对手划分，2021-2031年

全球外用伤口护理产品市场预计将从 2025 年的 19.7 亿美元成长到 2031 年的 31.2 亿美元，复合年增长率为 7.96%。

这些药物是专门配製的，直接应用于皮肤伤口，旨在促进癒合、预防感染和控制渗出液。该市场的成长主要受全球慢性疾病（例如糖尿病）盛行率上升的驱动，这些疾病显着增加了患者发生难癒合性溃疡的风险。根据国际糖尿病联盟 (IDF) 预测，到 2024 年，全球将有约 5.89 亿成年人患有糖尿病，这将持续推动对有效创伤护理解决方案的需求。此外，人口老化也促进了市场扩张，因为与老龄化相关的生理变化会延缓伤口缝合，因此需要更长的治疗通讯协定。

然而，由于抗生素抗药性威胁日益加剧，市场面临许多重大挑战。抗药性菌株的增加降低了标准外用抗生素的疗效，使治疗方案复杂化，并对临床结果产生负面影响。这项挑战迫使监管机构实施更严格的核准指南，导致製造商的研发成本增加，研发週期延长。因此，开发符合不断变化的合理抗生素使用标准的创新疗法仍然是阻碍市场整体成长的一大障碍。

市场驱动因素

需要术后伤口管理的外科手术数量不断增加，是推动市场扩张的主要因素。从整形外科置换术到美容整形手术都会产生急性伤口。专业的局部护理对于确保伤口缝合、控制渗出液和最大限度减少手术部位感染（SSI）至关重要。随着全球手术数量的增长，旨在优化癒合和降低再入院率的先进敷料、密封剂和负压伤口治疗（NPWT）设备的消耗量也在增加。国际美容整形外科学会（ISAPS）在2025年6月发布的报告也印证了这一趋势：2024年全球手术量将超过1740万例，这凸显了需要有效术后创伤护理解决方案的患者群体显着扩大。

生物活性和抗菌外用製剂的技术进步，透过满足慢性及难治性伤口的复杂需求，进一步推动了市场成长。细胞和组织衍生产品、含银敷料以及生物膜破坏剂等创新技术，因其能够更有效地调节伤口环境并对抗抗生素抗药性，正逐步取代传统的被动治疗方法。这种向高效、高品质产品的转变，不仅提高了製造商的获利能力，也改善了抗生素抗药性感染疾病患者的治疗效果。例如，史密斯医疗（Smith & Nephew）公司报告称，其生物活性伤口护理产品在2025年2月的核心收入增长了20.3%；同年4月，莫尔尼克医疗（Molnlycke Healthcare）宣布其年销售额达到20.64亿欧元。这些都显示，全球对创新创伤护理技术的需求十分旺盛。

市场挑战

抗生素抗药性的日益严重对全球外用伤口护理产品市场构成重大挑战。随着细菌对标准疗法产生抗药性，现有局部抗生素的临床效用下降，迫使医疗机构限制其使用以维持有效性。这场抗药性危机导致监管机构实施了严格的核准要求，并要求进行复杂且高成本的临床试验，以证明其优于现有标准。因此，製造商面临更高的研发成本和更长的开发週期，显着降低了新型创伤护理配方的投资报酬率。

研发能够有效中和抗药性菌株并严格遵守控制通讯协定的新型化合物，其科学难度之大，加剧了这项挑战。目前的开发平臺中，创新缺口显而易见。根据国际药品製造商协会联合会（IFPMA）统计，在2024年被列为高优先级的四种针对细菌病原体的候选抗生素中，仅有一种进入了III期临床试验。后期候选药物的匮乏凸显了企业在将新型高效能外用製剂推向市场方面面临的严峻挑战，直接限制了产业发展。

市场趋势

奈米技术的应用正在革新局部製剂领域，它能够开发出先进的递送系统，从而提高抗菌和创伤治疗化合物的治疗指数。与传统製剂不同，脂质奈米颗粒和金属奈米复合材料等奈米载体能够更有效地渗透到复杂的伤口组织和緻密的细菌生物膜中，使活性成分能够持续释放到感染部位。这种精准性显着加速了慢性溃疡的组织修復机制，同时降低了全身毒性的风险。作为其有效性的证据，圣保罗州研究基金会（FAPESP）于2025年3月重点报导的一项研究表明，可再生，一种新开发的银奈米颗粒浸渍纤维素敷料在复杂皮肤损伤中实现了超过97%的平均伤口收缩率。

同时，在严格的抗菌药物使用规范和多重抗药性病原体危机日益严峻的推动下，市场正经历着从传统局部抗生素到非抗生素抗菌剂的重大转变。製造商正优先开发利用离子化银、界面活性剂和抗菌肽等替代抗菌剂的敷料和药物，这些抗菌剂能够有效灭活病原体且不会诱导抗药性。随着医疗机构寻求永续的感染控制解决方案，这项策略转变不仅满足了监管要求，也显着提升了该领域的收入。例如，康维特集团（ConvaTec Group）报告称，其创伤护理业务在2025年2月实现了7.4%的有机收入成长，这主要得益于市场对含银非抗生素抗菌敷料（如Aquacel Ag+Extra）的强劲需求。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球伤口敷料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类别（乳霜、凝胶、喷雾、其他）
  • 按应用（慢性伤口、急性伤口）
  • 依最终用途（医院、诊所、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球伤口敷料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Smith+Nephew Plc
• MOlnlycke Health Care AB
• Teva Pharmaceutical Industries Ltd.
• Arch Therapeutics, Inc.
• Viatris Inc.
• Ipca Laboratories Ltd.
• CHIESI USA, Inc.
• Altrazeal Life Sciences Inc.
• Inotec AMD Ltd.
• The Wound Company

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Topical Wound Agents Market is projected to expand from USD 1.97 Billion in 2025 to USD 3.12 Billion by 2031, reflecting a compound annual growth rate of 7.96%. These agents are specialized formulations applied directly to skin injuries to promote healing, prevent infection, and manage exudate. The market is largely driven by the rising global burden of chronic conditions such as diabetes, which significantly increases patient susceptibility to non-healing ulcers. According to the International Diabetes Federation, approximately 589 million adults were living with diabetes globally in 2024, creating a sustained demand for effective wound care solutions. Additionally, the growing geriatric population contributes to market expansion, as age-related physiological changes slow wound closure, necessitating extended treatment protocols.

However, the market encounters a major obstacle due to the escalating threat of antimicrobial resistance. The rise of resistant bacterial strains reduces the effectiveness of standard topical antibiotics, complicating treatment plans and negatively impacting clinical outcomes. This challenge compels regulatory authorities to enforce stricter approval guidelines, which subsequently increases development costs and extends timelines for manufacturers. Consequently, the difficulty in developing novel therapeutics that align with evolving antibiotic stewardship standards remains a critical barrier that could hinder broader market growth.

Market Driver

The increasing volume of surgical procedures requiring post-operative wound management acts as a primary catalyst for market expansion. Surgical interventions, ranging from orthopedic replacements to aesthetic reconstructions, inherently create acute wounds that demand specialized topical care to ensure proper closure, control exudate, and minimize surgical site infections (SSIs). As the number of operations rises globally, so does the consumption of advanced dressings, sealants, and negative pressure wound therapy devices designed to optimize healing and reduce hospital readmissions. Highlighting this trend, the International Society of Aesthetic Plastic Surgery (ISAPS) reported in June 2025 that over 17.4 million surgical procedures were performed worldwide in 2024, emphasizing the substantial and growing patient pool requiring effective post-surgical wound care solutions.

Technological advancements in bioactive and antimicrobial topical formulations are further driving market growth by addressing the complex needs of chronic and hard-to-heal wounds. Innovations such as cellular and tissue-based products, silver-impregnated dressings, and biofilm-disrupting agents are increasingly replacing traditional passive therapies due to their superior ability to modulate the wound environment and combat antimicrobial resistance. This shift toward high-efficacy, premium products is boosting manufacturer revenues and improving outcomes for patients with resistant infections. For instance, Smith & Nephew reported in February 2025 that their Advanced Wound Bioactives segment achieved 20.3% underlying revenue growth, while Molnlycke Health Care announced annual sales of EUR 2,064 million in April 2025, underscoring the robust global demand for innovative wound care technologies.

Market Challenge

The rising threat of antimicrobial resistance presents a formidable barrier to the Global Topical Wound Agents Market. As bacteria evolve to withstand standard treatments, the clinical utility of existing topical antibiotics diminishes, forcing healthcare providers to restrict their usage to preserve efficacy. This resistance crisis drives regulatory agencies to enforce stringent approval requirements, necessitating complex and expensive clinical trials to demonstrate superiority over current standards. Consequently, manufacturers face escalated research and development costs alongside prolonged timelines, which significantly reduces the return on investment for new wound care formulations.

This challenge is further exacerbated by the scientific difficulty in discovering novel compounds that can effectively neutralize resistant strains while complying with rigorous stewardship protocols. This innovation gap is evident in the current development pipeline. According to the International Federation of Pharmaceutical Manufacturers and Associations, there was only one antibiotic candidate in Phase III clinical trials targeting the four bacterial pathogens classified as critical priorities in 2024. This scarcity of late-stage candidates highlights the profound obstacles companies face in bringing new, effective topical agents to market, directly constraining sector growth.

Market Trends

The application of nanotechnology is revolutionizing the topical agents sector by enabling the development of advanced delivery systems that enhance the therapeutic index of antimicrobial and healing compounds. Unlike traditional formulations, nanocarriers such as lipid nanoparticles and metal nanocomposites offer superior penetration into complex wound topographies and dense bacterial biofilms, ensuring sustained release of active ingredients directly at the infection site. This precision reduces systemic toxicity risks while significantly accelerating tissue repair mechanisms in chronic ulcers. Validating this efficacy, Agencia FAPESP highlighted a study in March 2025 where a novel silver nanoparticle-impregnated cellulose dressing achieved an average wound contraction rate of more than 97% in complex skin lesions, demonstrating the potent regenerative potential of these nanoscale interventions.

Concurrently, there is a decisive market shift away from conventional topical antibiotics toward non-antibiotic antimicrobial formulations, driven by stringent antibiotic stewardship programs and the escalating crisis of multidrug-resistant pathogens. Manufacturers are increasingly prioritizing the commercialization of dressings and agents utilizing alternative biocides, such as ionic silver, surfactants, and antimicrobial peptides, which effectively neutralize pathogens without inducing resistance. This strategic pivot meets regulatory demands and drives substantial segment revenue as healthcare providers seek durable infection control solutions. For example, Convatec Group Plc reported in February 2025 that its Advanced Wound Care business recorded 7.4% organic revenue growth, a performance primarily attributed to the robust demand for its silver-containing, non-antibiotic antimicrobial dressings like Aquacel Ag+ Extra.

Key Market Players

• Smith+Nephew Plc
• MOlnlycke Health Care AB
• Teva Pharmaceutical Industries Ltd.
• Arch Therapeutics, Inc.
• Viatris Inc.
• Ipca Laboratories Ltd.
• CHIESI USA, Inc.
• Altrazeal Life Sciences Inc.
• Inotec AMD Ltd.
• The Wound Company

Report Scope

In this report, the Global Topical Wound Agents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Topical Wound Agents Market, By Product

• Creams
• Gels
• Sprays
• Others

Topical Wound Agents Market, By Application

• Chronic Wounds
• Acute Wounds

Topical Wound Agents Market, By End Use

• Hospitals
• Clinics
• Others

Topical Wound Agents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Topical Wound Agents Market.

Available Customizations:

Global Topical Wound Agents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Topical Wound Agents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Creams, Gels, Sprays, Others)
  • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
  • 5.2.3. By End Use (Hospitals, Clinics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Topical Wound Agents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Topical Wound Agents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Topical Wound Agents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Topical Wound Agents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Topical Wound Agents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Topical Wound Agents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Topical Wound Agents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Topical Wound Agents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Topical Wound Agents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Topical Wound Agents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Topical Wound Agents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Topical Wound Agents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Topical Wound Agents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Topical Wound Agents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Topical Wound Agents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Topical Wound Agents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Topical Wound Agents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Topical Wound Agents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Topical Wound Agents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Topical Wound Agents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Topical Wound Agents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Topical Wound Agents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Topical Wound Agents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Topical Wound Agents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Topical Wound Agents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Smith+Nephew Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. MOlnlycke Health Care AB
• 15.3. Teva Pharmaceutical Industries Ltd.
• 15.4. Arch Therapeutics, Inc.
• 15.5. Viatris Inc.
• 15.6. Ipca Laboratories Ltd.
• 15.7. CHIESI USA, Inc.
• 15.8. Altrazeal Life Sciences Inc.
• 15.9. Inotec AMD Ltd.
• 15.10. The Wound Company

16. Strategic Recommendations

17. About Us & Disclaimer